Agreed, ICON is our LymPro partner. The speculatio
Post# of 30028
Posted On: 03/04/2015 7:39:50 PM
Re: seebisquick #17595
Agreed, ICON is our LymPro partner. The speculations generated by some on this board led to higher expectations, meaning a big pharma partner with large up-front cash, which now translates to blaming GC for misleading us.
Gerald can lay out 10 goals, hit 8 of them, and some will focus on the 2 he missed or that have been delayed. Memory recall also needs some work with a few here. We got our LymPro partner as promised. End of story.
I do wish the company would stop stating their goal to uplist to Nasdaq. We all know it will happen in time, but putting a timeline on it is foolish because no one, not even the company, can predict with any accuracy what events will transpire in a given timeline and what market conditions will be regarding the share price. It will happen when the company executes on revenue generation and a more realistic perception of the company value is realized.
Glad I own a ton of cheap shares. It certainly helps me to keep things in perspective for this long-haul investment. This story will continue to unfold with false steps, changing directions due to unanticipated roadblocks, and those who can't adapt to changes in plans will drive themselves crazy worrying about this investment. I look at the forest, not the individual trees.
Gerald can lay out 10 goals, hit 8 of them, and some will focus on the 2 he missed or that have been delayed. Memory recall also needs some work with a few here. We got our LymPro partner as promised. End of story.
I do wish the company would stop stating their goal to uplist to Nasdaq. We all know it will happen in time, but putting a timeline on it is foolish because no one, not even the company, can predict with any accuracy what events will transpire in a given timeline and what market conditions will be regarding the share price. It will happen when the company executes on revenue generation and a more realistic perception of the company value is realized.
Glad I own a ton of cheap shares. It certainly helps me to keep things in perspective for this long-haul investment. This story will continue to unfold with false steps, changing directions due to unanticipated roadblocks, and those who can't adapt to changes in plans will drive themselves crazy worrying about this investment. I look at the forest, not the individual trees.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼